Valirx (VAL)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

 0.46p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.77
  • 52 Week Low: 0.39
  • Currency: UK Pounds
  • Shares Issued: 1,711.18m
  • Volume: 3,699,507
  • Market Cap: £7.87m
  • RiskGrade: 269
  • Beta: 0.07

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
92.71% below the market average92.71% below the market average92.71% below the market average92.71% below the market average92.71% below the market average
63.16% below the sector average63.16% below the sector average63.16% below the sector average63.16% below the sector average63.16% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
70.43% above the market average70.43% above the market average70.43% above the market average70.43% above the market average70.43% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Price Book Ratio
29.43% below the market average29.43% below the market average29.43% below the market average29.43% below the market average29.43% below the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
55.05% below the market average55.05% below the market average55.05% below the market average55.05% below the market average55.05% below the market average
44% below the sector average44% below the sector average44% below the sector average44% below the sector average44% below the sector average
Price Chg 3m
72.63% below the market average72.63% below the market average72.63% below the market average72.63% below the market average72.63% below the market average
72% below the sector average72% below the sector average72% below the sector average72% below the sector average72% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
19.35% below the market average19.35% below the market average19.35% below the market average19.35% below the market average19.35% below the market average
31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average
Momentum 20
31.09% below the market average31.09% below the market average31.09% below the market average31.09% below the market average31.09% below the market average
23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
92.46% below the market average92.46% below the market average92.46% below the market average92.46% below the market average92.46% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
36.03% below the market average36.03% below the market average36.03% below the market average36.03% below the market average36.03% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.02% below the market average87.02% below the market average87.02% below the market average87.02% below the market average87.02% below the market average
73.68% below the sector average73.68% below the sector average73.68% below the sector average73.68% below the sector average73.68% below the sector average
Operating Profit Loss
64.02% below the market average64.02% below the market average64.02% below the market average64.02% below the market average64.02% below the market average
18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
56.23% below the market average56.23% below the market average56.23% below the market average56.23% below the market average56.23% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Cash
25.15% below the market average25.15% below the market average25.15% below the market average25.15% below the market average25.15% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.46p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.77
52 Week Low 0.39
Volume 3,699,507
Shares Issued 1,711.18m
Market Cap £7.87m
Beta 0.07
RiskGrade 269

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.3% below the market average14.3% below the market average14.3% below the market average14.3% below the market average14.3% below the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Trend
8.88% below the market average8.88% below the market average8.88% below the market average8.88% below the market average8.88% below the market average
8% below the sector average8% below the sector average8% below the sector average8% below the sector average8% below the sector average
Income Not Available
Growth
19.32% above the market average19.32% above the market average19.32% above the market average19.32% above the market average19.32% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average

Valirx Dividends

No dividends found

Trades for 24-May-2013

Time Volume / Share Price
16:22 300,000 @ 0.45p
15:34 42,000 @ 0.45p
15:02 8,172 @ 0.45p
14:21 106,957 @ 0.45p
14:06 107,409 @ 0.45p

Valirx Key Personnel

CFO Gerald Desler
CEO Satu Vainikka

Top of Page